You are here

Pfizer

Pfizer Spinoff Cerevel Therapeutics Begins Trading on the Nasdaq

BioSpace

Wed, 10/28/20 - 11:09 pm

Cerevel Therapeutics

How Pfizer Missed an Opportunity With Its Q3 Results

Motley Fool

Tue, 10/27/20 - 11:26 pm

Pfizer Q3 cull sees midstage fast-tracked NASH drug axed, with a cancer vaccine and arthritis asset also chopped

Fierce Pharma

Tue, 10/27/20 - 10:44 am

cancer vaccines

No news on Pfizer’s Covid-19 vaccine is good news — and bad news

Stat

Tue, 10/27/20 - 10:35 am

clinical trials

[video+transcript]What Are the Differences Between the Leading Coronavirus Vaccine Candidates?

Motley Fool

Sun, 10/25/20 - 11:24 pm

Moderna Therapeutics

[video + transcript]What's the Timeline for FDA Emergency Use Authorization of Coronavirus Vaccines?

Motley Fool

Sat, 10/24/20 - 11:31 pm

Emergency Use Authorization

At key meeting, FDA advisors debate if early coronavirus vaccine approvals may compromise trials

BioPharma Dive

Fri, 10/23/20 - 10:56 am

Moderna Therapeutics

IBM and Pfizer Believe Machine Learning Can Predict Alzheimer’s Risk

BioSpace

Thu, 10/22/20 - 11:21 pm

artificial intelligence

machine learning

Alzheimer's disease

Pfizer, Moderna COVID-19 vaccines could reach all Americans by June—if politics don't get in the way: Slaoui

Fierce Pharma

Thu, 10/22/20 - 11:10 am

Moderna Therapeutics

Operation Warp Speed

Planes, trucks and ultracold boxes: Pfizer preps massive COVID-19 vaccine distribution effort

Fierce Pharma

Thu, 10/22/20 - 10:45 am

Pfizer could haul in $3.5B in 2021 from COVID-19 vaccine: analyst

Fierce Pharma

Wed, 10/21/20 - 11:40 pm

COVID-19 vaccine biotech Vaccitech nabs Pfizer, Kite vet as full-time CMO

Fierce Biotech

Tue, 10/20/20 - 10:42 am

Merck's rival to Pfizer's Prevnar 13 hits goal in phase 3 again

Fierce Biotech

Tue, 10/20/20 - 10:38 am

clinical trials

pneumococcal disease

Pfizer: Expanding North Carolina Gene Therapy Facility and Adding Jobs

BioSpace

Mon, 10/19/20 - 11:24 pm

drug manufacturing

Pfizer CEO Anticipates EUA for COVID-19 Vaccine in Late November

BioSpace

Mon, 10/19/20 - 10:59 am

Emergency Use Authorization

clinical trials

Pfizer Reportedly Manufactures ‘Several Hundred Thousand’ Covid-19 Vaccines Anticipating November Regulatory Approval

Forbes

Mon, 10/19/20 - 10:57 am

drug manufacturing

Moderna Works With International Regulators to Speed Up COVID-19 Vaccine Review Process

BioSpace

Sat, 10/17/20 - 11:28 pm

Moderna Therapeutics

Pfizer to apply for COVID-19 vaccine EUA after mid-November safety data milestone

Biopharma Reporter

Fri, 10/16/20 - 11:18 am

Emergency Use Authorization

Will Kids Get A COVID-19 Vaccine? Pfizer To Expand Trial To Ages 12 And Up

NPR

Tue, 10/13/20 - 09:46 pm

clinical trials

Pfizer and BioNTech Coronavirus Vaccine Accepted for Rolling Review in Canada

Motley Fool

Mon, 10/12/20 - 05:58 pm

Pages